An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.
Grundman
M
M
Gilman
S
S
Black
R S
RS
Fox
N C
NC
Koller
M
M
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D000906:Antibodies / Q000032:analysis / Q000097:blood; D002986:Clinical Trials as Topic / Q000592:standards*; D003627:Data Interpretation, Statistical; D023381:Endpoint Determination / Q000379:methods* / Q000592:standards; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods* / Q000592:standards; D017063:Outcome Assessment, Health Care / Q000379:methods* / Q000592:standards; D015990:Placebo Effect; D016896:Treatment Outcome; D014612:Vaccines / Q000276:immunology / Q000494:pharmacology*
D000906:Antibodies; D014612:Vaccines